Paul Tudor Jones Sensei Biotherapeutics, Inc. Transaction History

Tudor Investment Corp Et Al

  • $26.8 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$6.89 - $11.99 $193,684 - $337,050
-28,111 Closed
0 $0
Q2 2021

Aug 16, 2021
SELL
$9.1 - $15.14 $775,702 - $1.29 Million
-85,242 Reduced 75.2%
28,111 $274,000
Q1 2021

May 17, 2021
BUY
$12.04 - $22.75 $1.36 Million - $2.58 Million
113,353 New
113,353 $1.65 Million

Others Institutions Holding SNSE

# of Institutions
22
Shares Held
2.23M
Call Options Held
0
Put Options Held
0
View Full List

About Sensei Biotherapeutics, Inc.

SNSE Quotes by TradingView
  • Ticker SNSE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,720,300
  • Market Cap $15.4M
  • Description
  • Sensei Biotherapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of immunotherapies with an initial focus on treatments for cancer. It develops proprietary ImmunoPhage platform, an immunotherapy approach that is designed to utilize bacteriophage to induce a focused and coordinated innate and adaptive immune res...
More about SNSE
Track Paul Tudor Jones's Portfolio

Track Paul Tudor Jones Portfolio

Follow Paul Tudor Jones (Tudor Investment Corp Et Al) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email